BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 8675091)

  • 1. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.
    Bansi DS; Fleming KA; Chapman RW
    Gut; 1996 Mar; 38(3):384-9. PubMed ID: 8675091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass.
    Bansi D; Chapman R; Fleming K
    J Hepatol; 1996 May; 24(5):581-6. PubMed ID: 8773914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Bansi DS; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
    Halbwachs-Mecarelli L; Nusbaum P; Noël LH; Reumaux D; Erlinger S; Grünfeld JP; Lesavre P
    Clin Exp Immunol; 1992 Oct; 90(1):79-84. PubMed ID: 1327593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis.
    Bansi DS; Lo S; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):111-6. PubMed ID: 8723413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.
    Bansi DS; Bauducci M; Bergqvist A; Boberg K; Broome U; Chapman R; Fleming K; Jorgensen R; Lindor K; Rosina F; Schrumpf E
    Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):575-80. PubMed ID: 9222729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens?
    Seibold F; Weber P; Schöning A; Mörk H; Goppel S; Scheurlen M
    Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1095-100. PubMed ID: 8944372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.
    Hov JR; Boberg KM; Taraldsrud E; Vesterhus M; Boyadzhieva M; Solberg IC; Schrumpf E; Vatn MH; Lie BA; Molberg Ø; Karlsen TH
    Liver Int; 2017 Mar; 37(3):458-465. PubMed ID: 27558072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis.
    Dobric S; Popovic D; Nikolic M; Andrejevic S; Spuran M; Bonaci-Nikolic B
    Clin Chem Lab Med; 2011 Nov; 50(3):503-9. PubMed ID: 22107137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis.
    Lenzen H; Weismüller TJ; Negm AA; Wlecke J; Loges S; Strassburg CP; Manns MP; Lankisch TO
    Scand J Gastroenterol; 2013 Oct; 48(10):1205-12. PubMed ID: 23957616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA.
    Mulder AH; Stegeman CA; Kallenberg CG
    Clin Exp Immunol; 1995 Aug; 101(2):227-32. PubMed ID: 7648707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel disease.
    Müller-Ladner U; Gross V; Andus T; Gschwendtner H; Roth M; Caesar I; Schölmerich J; Lang B
    Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):579-84. PubMed ID: 8823574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.
    Vidrich A; Lee J; James E; Cobb L; Targan S
    J Clin Immunol; 1995 Nov; 15(6):293-9. PubMed ID: 8576315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Proteinase 3 Antibodies as a Biomarker for Ulcerative Colitis and Primary Sclerosing Cholangitis in Children.
    Laass MW; Ziesmann J; de Laffolie J; Röber N; Conrad K
    J Pediatr Gastroenterol Nutr; 2022 Apr; 74(4):463-470. PubMed ID: 35703948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis.
    Ellerbroek PM; Oudkerk Pool M; Ridwan BU; Dolman KM; von Blomberg BM; von dem Borne AE; Meuwissen SG; Goldschmeding R
    J Clin Pathol; 1994 Mar; 47(3):257-62. PubMed ID: 8163698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders.
    Brouwer E; Tervaert JW; Horst G; Huitema MG; van der Giessen M; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1991 Mar; 83(3):379-86. PubMed ID: 1848489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis.
    Gao Y; Ye H; Yu F; Guo XH; Zhao MH
    Clin Immunol; 2005 Oct; 117(1):87-93. PubMed ID: 16019262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of perinuclear antineutrophil cytoplasmic antibodies in subjects with primary sclerosing cholangitis.
    Guglielmi V; Giorgio P; Guerra V; Sonnante A; Tutino M; Donghia R; Pisani A
    Minerva Med; 2022 Jun; 113(3):513-517. PubMed ID: 32407046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis.
    Dalekos GN; Manoussakis MN; Goussia AC; Tsianos EV; Moutsopoulos HM
    Gut; 1993 May; 34(5):658-64. PubMed ID: 8504967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
    Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F
    Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.